Actelion to discuss first half 2015 financial results

Actelion to discuss first half 2015 financial results

ID: 407420

(Thomson Reuters ONE) -
Actelion Pharmaceuticals Ltd /
Actelion to discuss first half 2015 financial results
. Processed and transmitted by NASDAQ OMX Corporate Solutions.
The issuer is solely responsible for the content of this announcement.

Dear member of the investment community

Actelion Ltd will announce its half-year 2015 financial results on Tuesday, 21
July 2015, at 07:00hrs CEST / 06:00hrs BST / 1.00 a.m. EDT.

An investor conference call & webcast will be held at 14:00hrs, CEST to discuss
the results.

To support your preparations, consensus estimates can be found under
www.actelion.com/consensus-estimate



Date/Time:



21 July 2015 14:00hrs - 14:45hrs Basel (CEST)

  13:00hrs - 13:45hrs UK (BST)

  8.00 a.m. - 8.45 a.m. US (EDT)





Conference Call Connect #:

Dial-in participants should start calling the number below 10-15 minutes before
the conference is due to start.



Dial: Europe: +41 (0)44 583 18 01

  UK: +44 (0) 203 194 05 61

  US: +1 855 228 38 74





Participant's mode:

Listen-Only with possibility to open individual lines during Q&A session.
Participants will be asked for their Name and Company.



Webcast Access:

Webcast participants should visit the Actelion website www.actelion.com 10-15
minutes before the conference is due to start.

Participant's mode: Listen-Only



Webcast Replay:

The archived Investor Webcast will be available for replay through
www.actelion.com approximately 60 minutes after the call has ended.



Invitation PDF:
http://hugin.info/131801/R/1939257/699573.pdf



This announcement is distributed by GlobeNewswire on behalf of




GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.

Source: Actelion Pharmaceuticals Ltd via GlobeNewswire
[HUG#1939257]




Weitere Infos zu dieser Pressemeldung:
Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Veidekke ASA: Veidekke and DEC to carry out remediation of historic refinery site for ESSO Norge AS Notification in accordance with section 26 paragraph 1 WpHG with the objective of Europe-wide distribution
Bereitgestellt von Benutzer: hugin
Datum: 16.07.2015 - 17:35 Uhr
Sprache: Deutsch
News-ID 407420
Anzahl Zeichen: 2584

contact information:
Town:

Allschwil



Kategorie:

Business News



Diese Pressemitteilung wurde bisher 126 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Actelion to discuss first half 2015 financial results"
steht unter der journalistisch-redaktionellen Verantwortung von

Actelion Pharmaceuticals Ltd (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Actelion Pharmaceuticals Ltd



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z